Read + Share
Cheng DK, Oni TE, Thalappillil JS, Park Y, et al. Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in
pancreatic cancer. Proc Natl Acad Sci U S A 2021;118.
PMID: 34021083
|
 |
|
Cheng DK, Oni TE, Thalappillil JS, Park Y, et al. Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in
pancreatic cancer. Proc Natl Acad Sci U S A 2021;118.
PMID: 34021083
|
|
|
|